Stock 4109 JIA JIE BIOMEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jia Jie Biomedical Co., Ltd.

Equities

4109

TW0004109004

Food Processing

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 28/05/2024 am IST 		5-day change 1st Jan Change
20.55 TWD -0.96% Intraday chart for Jia Jie Biomedical Co., Ltd. +1.23% +19.48%
11/05 Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
26/03 Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 966.5 1,393 1,224 1,192 1,307 1,530
Enterprise Value (EV) 1 1,110 1,373 883.6 912.1 1,062 1,389
P/E ratio 391 x -56.1 x -38.6 x 223 x -239 x 10.6 x
Yield - - - - - 2.91%
Capitalization / Revenue 2.4 x 4.06 x 4.53 x 4.91 x 4.11 x 4.6 x
EV / Revenue 2.76 x 4 x 3.27 x 3.76 x 3.34 x 4.18 x
EV / EBITDA -41.8 x -226 x -24.4 x 90.8 x -1,848 x -25.6 x
EV / FCF -15.8 x 8.6 x 25.6 x -202 x -38 x 535 x
FCF Yield -6.33% 11.6% 3.9% -0.5% -2.63% 0.19%
Price to Book 1.37 x 2 x 1.74 x 1.31 x 1.46 x 1.46 x
Nbr of stocks (in thousands) 68,937 68,936 68,937 88,937 88,937 88,937
Reference price 2 14.02 20.20 17.75 13.40 14.70 17.20
Announcement Date 01/04/19 31/03/20 31/03/21 30/03/22 31/03/23 26/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 402 343.1 270.3 242.5 317.7 332.8
EBITDA 1 -26.55 -6.074 -36.18 10.05 -0.575 -54.19
EBIT 1 -42.3 -20.7 -48.33 -0.93 -13.68 -66.2
Operating Margin -10.52% -6.03% -17.88% -0.38% -4.31% -19.89%
Earnings before Tax (EBT) 1 2.76 -25.46 -41.65 5.29 -4.68 146.5
Net income 1 2.474 -24.48 -31.92 5.34 -5.47 144.1
Net margin 0.62% -7.14% -11.81% 2.2% -1.72% 43.32%
EPS 2 0.0359 -0.3600 -0.4600 0.0600 -0.0615 1.620
Free Cash Flow 1 -70.24 159.6 34.49 -4.524 -27.97 2.598
FCF margin -17.47% 46.52% 12.76% -1.87% -8.8% 0.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - 1.8%
Dividend per Share - - - - - 0.5000
Announcement Date 01/04/19 31/03/20 31/03/21 30/03/22 31/03/23 26/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 144 - - - - -
Net Cash position 1 - 19.4 340 280 245 140
Leverage (Debt/EBITDA) -5.415 x - - - - -
Free Cash Flow 1 -70.2 160 34.5 -4.52 -28 2.6
ROE (net income / shareholders' equity) 0.05% -3.47% -4.08% 0.55% -0.69% 14.7%
ROA (Net income/ Total Assets) -2.17% -1.31% -3.27% -0.06% -0.84% -3.42%
Assets 1 -114.2 1,868 975.1 -9,239 647.8 -4,210
Book Value Per Share 2 10.30 10.10 10.20 10.20 10.10 11.80
Cash Flow per Share 2 2.250 1.510 3.870 1.940 1.410 3.990
Capex 1 8.34 3.05 1.63 1.52 18.1 8.61
Capex / Sales 2.07% 0.89% 0.6% 0.63% 5.69% 2.59%
Announcement Date 01/04/19 31/03/20 31/03/21 30/03/22 31/03/23 26/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
JIA JIE BIOMEDICAL CO., LTD. Stock Jia Jie Biomedical Co., Ltd.
+19.48% 63.02M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.74% 8.18B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+5.29% 7.53B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
-0.42% 5.89B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-6.67% 3.7B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-10.75% 3.57B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-8.21% 1.26B
HERBALIFE LTD. Stock Herbalife Ltd.
-29.10% 1.08B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+14.92% 991M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-12.46% 894M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 4109 Stock
  4. Financials Jia Jie Biomedical Co., Ltd.